Aventis Pharma S.A. v. Amphastar Pharmaceuticals Inc.

Core Citations

DISTINGUISHES

• Chupp, In re

This document cites

• Federal Cases - GFI Inc v. Franklin Corp
• Federal Cases - Brasseler v. Stryker Sales
• Federal Cases - Merck & Co., Inc. v. Danbury Pharmacal, Inc.
• Federal Cases - Hoffmann-La Roche, Inc. v. Promega Corp.
• Federal Cases - FMC Corp. v. Manitowoc Co., Inc.



See all quotations

• Federal Cases - Kingsdown Medical Consultants, Ltd. v. Hollister Inc.
• Federal Cases - Warner-Lambert Co. v. Teva Pharmaceuticals Usa
• Federal Cases - Frazier v. Roessel Cine Photo Tech, Inc.
• Federal Cases - Pharmacia Corp. v. Par Pharmaceutical, Inc., 04-1478
• Federal Cases - Critikon, Inc. v. Becton Dickinson Vascular Access, Inc.
• Federal Cases - University of West Virginia v. Vanvoorhies, 00-1440.
• Federal Cases - Purdue Pharma v. Boehring Ingelheim
• Federal Cases - Ferring B.V. v. Barr Laboratories, Inc.
• Federal Cases - Semiconductor Energy Lab. v. Samsung Elec.
• Federal Cases - Union Oil Co. of California v. Atlantic Richfield
• Federal Cases - Dayco Products, Inc. v. Total Containment, Inc.
• Federal Cases - Bruno Independent Living v. Acorn Mobility
• Federal Cases - Manville Sales Corp. v. Paramount Systems, Inc.
• Federal Cases - Ulead Systems v. Lex Computer & Management
• Federal Cases - Digital Control, Inc. v. Charles Mach. Works
• Federal Cases - Aventis Pharma S.A. v. Amphastar Pharmaceuticals
• Federal Cases - Bristol-Myers Squibb v. Rhone-Poulenc Rorer
• Federal Cases - Paragon Podiatry Laboratory, Inc. v. KLM Laboratories, Inc.
• US - Reference Stubs - Conditions for patentability; non-obvious subject matter
• US - Reference Stubs - Conditions for patentability; novelty